Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Authors
Keywords
-
Journal
Genes and Diseases
Volume 10, Issue 4, Pages 1367-1401
Publisher
Elsevier BV
Online
2022-03-18
DOI
10.1016/j.gendis.2022.02.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anticancer Applications and Pharmacological Properties of Piperidine and Piperine: A Comprehensive Review on Molecular Mechanisms and Therapeutic Perspectives
- (2022) Sicon Mitra et al. Frontiers in Pharmacology
- Safer plant-based nanoparticles for combating antibiotic resistance in bacteria: A comprehensive review on its potential applications, recent advances, and future perspective
- (2022) Uttpal Anand et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Therapeutic strategies to overcome taxane resistance in cancer
- (2021) Tuyelee Das et al. DRUG RESISTANCE UPDATES
- Targeting adenosine and regulatory T cells in cancer immunotherapy
- (2021) Alexey Churov et al. HUMAN IMMUNOLOGY
- Immune checkpoint inhibitors
- (2021) Guido Kroemer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Advancing oncolytic virus therapy by understanding the biology
- (2021) Howard L. Kaufman et al. Nature Reviews Clinical Oncology
- The Chemistry of Nonclassical Taxane Diterpene
- (2021) Fabian Schneider et al. ACCOUNTS OF CHEMICAL RESEARCH
- Antimicrobial peptides against colorectal cancer-a focused review
- (2021) Sonia Chauhan et al. PHARMACOLOGICAL RESEARCH
- Therapeutic Targeting of the Tumor Microenvironment
- (2021) Leire Bejarano et al. Cancer Discovery
- Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy
- (2021) Iris Lodewijk et al. Clinical Epigenetics
- Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma
- (2021) Pier Francesco Ferrucci et al. Cancers
- Colonic epithelial cathelicidin ( LL ‐37) expression intensity is associated with progression of colorectal cancer and presence of CD8 + T cell infiltrate
- (2021) Ross J Porter et al. Journal of Pathology Clinical Research
- TCR gene-engineered cell therapy for solid tumors
- (2021) Elaine Tan et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Adenosine and Inflammation: Here, There and Everywhere
- (2021) Silvia Pasquini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Wonder or evil?: Multifaceted health hazards and health benefits of Cannabis sativa and its phytochemicals
- (2021) Shivika Datta et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Exploring Phytochemicals for Combating Antibiotic Resistance in Microbial Pathogens
- (2021) Tushar Khare et al. Frontiers in Pharmacology
- The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
- (2021) Saikat Dewanjee et al. Cells
- Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges
- (2021) Guoqiang Sun et al. Frontiers in Cell and Developmental Biology
- Dioscin: A review on pharmacological properties and therapeutic values
- (2021) Shinjini Bandopadhyay et al. BIOFACTORS
- Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects
- (2021) Subhabrata Paul et al. BIOMEDICINE & PHARMACOTHERAPY
- Neoechinulins: Molecular, cellular, and functional attributes as promising therapeutics against cancer and other human diseases
- (2021) Sicon Mitra et al. BIOMEDICINE & PHARMACOTHERAPY
- Molecular Analysis of Elements of Melanoma Insensitivity to TCR-Engineered Adoptive Cell Therapy
- (2021) Ali R. Jazirehi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ethnodermatological use of medicinal plants in India: From ayurvedic formulations to clinical perspectives – A review
- (2021) Uttpal Anand et al. JOURNAL OF ETHNOPHARMACOLOGY
- Structure-Based Design of Dual-Acting Compounds Targeting Adenosine A2A Receptor and Histone Deacetylase as Novel Tumor Immunotherapeutic Agents
- (2021) Wenzhong Yan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combating Drug-Resistant Bacteria Using Photothermally Active Nanomaterials: A Perspective Review
- (2021) Kawaljeet Kaur et al. Frontiers in Microbiology
- Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
- (2021) Varda Shoshan-Barmatz et al. Frontiers in Physiology
- Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy
- (2021) Rafael Franco et al. Cells
- Atezolizumab for the treatment of breast cancer
- (2020) Sangeetha M. Reddy et al. Expert Review of Anticancer Therapy
- Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
- (2020) Merry Jennifer Markham et al. JOURNAL OF CLINICAL ONCOLOGY
- CAR T cells: continuation in a revolution of immunotherapy
- (2020) Anurag K Singh et al. LANCET ONCOLOGY
- How autophagy can restore proteostasis defects in multiple diseases?
- (2020) Vibhuti Joshi et al. MEDICINAL RESEARCH REVIEWS
- Metabolic Cycles in Cancer Cells?
- (2020) Andrew Moore BIOESSAYS
- Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy
- (2020) Jie Zhao et al. CANCER LETTERS
- The future of cancer immunotherapy: microenvironment-targeting combinations
- (2020) Yonina R. Murciano-Goroff et al. CELL RESEARCH
- Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
- (2020) Connie Kang et al. DRUGS
- Atezolizumab in the treatment of metastatic triple-negative breast cancer
- (2020) José Pérez-García et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Soyasapogenol-A targets CARF and results in suppression of tumor growth and metastasis in p53 compromised cancer cells
- (2020) Amr Omar et al. Scientific Reports
- Circulating Tumor DNA Testing—Liquid Biopsy of a Cancer
- (2020) Kyrillus S. Shohdy et al. JAMA Oncology
- Autophagy Induced by Proteasomal DUB Inhibitor NiPT Restricts NiPT-Mediated Cancer Cell Death
- (2020) Jinghong Chen et al. Frontiers in Oncology
- Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment
- (2020) Xingyi Pan et al. Cellular & Molecular Immunology
- Rethinking the adenosine-A2AR checkpoint: implications for enhancing anti-tumor immunotherapy
- (2020) Rachel S Helms et al. CURRENT OPINION IN PHARMACOLOGY
- Targeting Tumor‐Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies
- (2020) Ligong Lu et al. HEPATOLOGY
- Adenosine A2A Receptor Antagonists for Cancer Immunotherapy
- (2020) Fazhi Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial
- (2020) Panagiotis A Konstantinopoulos et al. LANCET ONCOLOGY
- Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
- (2020) Anna Lucia Tornesello et al. MOLECULES
- The adenosine pathway in immuno-oncology
- (2020) Bertrand Allard et al. Nature Reviews Clinical Oncology
- How Does the Interval Between Completion of Adjuvant Chemotherapy and Initiation of Radiotherapy Impact Clinical Outcomes in Operable Breast Cancer Patients?
- (2020) Lu Cao et al. ANNALS OF SURGICAL ONCOLOGY
- Decitabine/Cedazuridine: First Approval
- (2020) Sohita Dhillon DRUGS
- Carboplatin plus etoposide or topotecan for small-cell lung cancer
- (2020) Oscar Arrieta et al. LANCET ONCOLOGY
- Human cathelicidin antimicrobial peptide suppresses proliferation, migration and invasion of oral carcinoma HSC-3 cells via a novel mechanism involving caspase-3 mediated apoptosis
- (2020) Xi Chen et al. Molecular Medicine Reports
- Emerging connectivity of programmed cell death pathways and its physiological implications
- (2020) Sammy Bedoui et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Safety and Tolerability of Adoptive Cell Therapy in Cancer
- (2019) Benita Wolf et al. DRUG SAFETY
- Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency
- (2019) Olga Kutova et al. Cancers
- Cathelicidin Suppresses Colon Cancer Metastasis via a P2RX7-Dependent Mechanism
- (2019) Jiani Wang et al. Molecular Therapy-Oncolytics
- High content screening identifies monensin as an EMT-selective cytotoxic compound
- (2019) Marion Vanneste et al. Scientific Reports
- From Antimicrobial to Anticancer Peptides: The Transformation of Peptides
- (2019) Yuan Qin et al. Recent Patents on Anti-Cancer Drug Discovery
- DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents
- (2019) Maria Raimondi et al. MOLECULES
- Recent advances in triple negative breast cancer: the immunotherapy era
- (2019) Antonio Marra et al. BMC Medicine
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reorganization of paclitaxel-stabilized microtubule arrays at mitotic entry: roles of depolymerizing kinesins and severing proteins
- (2019) Jessica C. Leung et al. CANCER BIOLOGY & THERAPY
- Drug-induced gene expression profile changes in relation to intestinal toxicity: State-of-the-art and new approaches
- (2019) Daniela Rodrigues et al. CANCER TREATMENT REVIEWS
- Progress in research on paclitaxel and tumor immunotherapy
- (2019) Linyan Zhu et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- New insight into NANOG: A novel therapeutic target for ovarian cancer (OC)
- (2019) Iyer Mahalaxmi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
- (2019) Daniela Matei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Revisiting the hallmarks of cancer: The role of hyaluronan
- (2019) Ilaria Caon et al. SEMINARS IN CANCER BIOLOGY
- Inhibition of DNA Repair Mechanisms and Induction of Apoptosis in Triple Negative Breast Cancer Cells Expressing the Human Herpesvirus 6 U94
- (2019) Francesca Caccuri et al. Cancers
- Natural compounds as potential adjuvants to cancer therapy: preclinical evidence
- (2019) Shian‐Ren Lin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma
- (2019) Mark Yarchoan et al. CANCER RESEARCH
- Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
- (2019) Chloé Laplagne et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology
- (2019) Kaustav Bera et al. Nature Reviews Clinical Oncology
- Clinical Applications of Antimicrobial Peptides (AMPs): where do we stand now?
- (2019) Divyashree M. et al. PROTEIN AND PEPTIDE LETTERS
- Targeting Oncogenic BRAF: Past, Present, and Future
- (2019) Zaman et al. Cancers
- Highlights in Resistance Mechanism Pathways for Combination Therapy
- (2019) Delou et al. Cells
- Comparison of Tissue and Blood Concentrations of Oxaliplatin Administrated by Different Modalities of Intraperitoneal Chemotherapy
- (2019) Urs Giger-Pabst et al. ANNALS OF SURGICAL ONCOLOGY
- Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors
- (2019) Rachel Grosser et al. CANCER CELL
- Cancer Nanomedicine: A New Era of Successful Targeted Therapy
- (2019) Mahmoud Zaki El-Readi et al. Journal of Nanomaterials
- Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas
- (2019) Prakirthi Yerram et al. JOURNAL OF NEURO-ONCOLOGY
- Irinotecan: 25 years of cancer treatment
- (2019) Christian Bailly PHARMACOLOGICAL RESEARCH
- 2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental Evidences
- (2019) Anupama Chaudhary et al. Scientific Reports
- Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion
- (2019) Peter Kreuzaler et al. Molecular Metabolism
- Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
- (2019) Tala M. Abu Samaan et al. Biomolecules
- A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery
- (2019) Uttpal Anand et al. Metabolites
- Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
- (2019) Ulrich Jäger et al. BLOOD REVIEWS
- Targeting innate sensing in the tumor microenvironment to improve immunotherapy
- (2019) Zhida Liu et al. Cellular & Molecular Immunology
- Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
- (2018) Emanuela Martino et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
- (2018) Femke M. de Man et al. CLINICAL PHARMACOKINETICS
- Next Generation Antineoplastic Agents: A Review on Structurally Modified Vinblastine (VBL) Analogues
- (2018) Ashanul Haque et al. CURRENT MEDICINAL CHEMISTRY
- The evolving role of DNA inter-strand crosslinks in chemotherapy
- (2018) Halley B Rycenga et al. CURRENT OPINION IN PHARMACOLOGY
- Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer
- (2018) Martin Reck Immunotherapy
- Vinorelbine’s anti-tumor actions may depend on the mitotic apoptosis, autophagy and inflammation: hypotheses with implications for chemo-immunotherapy of advanced cancers and pediatric gliomas
- (2018) Meric A. Altinoz et al. JOURNAL OF CHEMOTHERAPY
- Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features
- (2018) Tsetan Dolkar et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Proteasome-mediated proteostasis: Novel medicinal and pharmacological strategies for diseases
- (2018) Ribhav Mishra et al. MEDICINAL RESEARCH REVIEWS
- Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences
- (2018) Lorena Infante Lara et al. NUCLEIC ACIDS RESEARCH
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- Progress and challenges towards targeted delivery of cancer therapeutics
- (2018) Daniel Rosenblum et al. Nature Communications
- Tumor suppressor activity of miR-451: Identification of CARF as a new target
- (2018) Ling Li et al. Scientific Reports
- Antimicrobial Peptides and Nanotechnology, Recent Advances and Challenges
- (2018) Lubhandwa S. Biswaro et al. Frontiers in Microbiology
- From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity
- (2018) Guido Gambara et al. Frontiers in Pharmacology
- CARF enrichment promotes epithelial–mesenchymal transition via Wnt/β-catenin signaling: its clinical relevance and potential as a therapeutic target
- (2018) Rajkumar S. Kalra et al. Oncogenesis
- Innovative Technologies Changing Cancer Treatment
- (2018) Sara Charmsaz et al. Cancers
- Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cells
- (2018) Sara Sannino et al. JOURNAL OF CELL SCIENCE
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival
- (2018) SM Gilbert et al. ONCOGENE
- Principles of adoptive T cell therapy in cancer
- (2018) Özcan Met et al. Seminars in Immunopathology
- Biophysics of Tumor Microenvironment and Cancer Metastasis - A Mini Review
- (2018) Bashar Emon et al. Computational and Structural Biotechnology Journal
- FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
- (2018) Aviva C Krauss et al. CLINICAL CANCER RESEARCH
- Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
- (2018) Hannah A. Blair DRUGS
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Anticancer Activity of Natural Compounds from Plant and Marine Environment
- (2018) Anna Lichota et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cell metabolomics identify regulatory pathways and targets of magnoline against prostate cancer
- (2018) Hui Sun et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?
- (2018) Jean Jacques Grob et al. LANCET ONCOLOGY
- Therapeutic Potential of Nitrogen Mustard Based Hybrid Molecules
- (2018) Yiming Chen et al. Frontiers in Pharmacology
- Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
- (2018) Luca Falzone et al. Frontiers in Pharmacology
- Lowering Etoposide Doses Shifts Cell Demise From Caspase-Dependent to Differentiation and Caspase-3-Independent Apoptosis via DNA Damage Response, Inducing AML Culture Extinction
- (2018) Emanuele Bruni et al. Frontiers in Pharmacology
- Cytarabine and daunorubicin for the treatment of acute myeloid leukemia
- (2017) Tracy Murphy et al. EXPERT OPINION ON PHARMACOTHERAPY
- Analysis of lomustine drug content in FDA-approved and compounded lomustine capsules
- (2017) Butch KuKanich et al. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
- Oral adjuvant chemotherapy using uracil-tegafur (UFT) with leucovorin (LV) after resection of colorectal cancer liver metastases: Long-term survival results of the phase III UFT/LV study.
- (2017) Kiyoshi Hasegawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Advances in nano-delivery systems for doxorubicin: an updated insight
- (2017) Ummarah Kanwal et al. JOURNAL OF DRUG TARGETING
- 2,3-Dihydro-3β-methoxy Withaferin-A Protects Normal Cells against Stress: Molecular Evidence of Its Potent Cytoprotective Activity
- (2017) Anupama Chaudhary et al. JOURNAL OF NATURAL PRODUCTS
- Future cancer research priorities in the USA: a Lancet Oncology Commission
- (2017) Elizabeth M Jaffee et al. LANCET ONCOLOGY
- CARF is a multi-module regulator of cell proliferation and a molecular bridge between cellular senescence and carcinogenesis
- (2017) Renu Wadhwa et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Emerging Cytotoxic Alkaloids in the Battle against Cancer: Overview of Molecular Mechanisms
- (2017) Zeina Habli et al. MOLECULES
- Engineered cell therapy for cancer gets thumbs up from FDA advisers
- (2017) Heidi Ledford NATURE
- Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
- (2017) Norikazu Masuda et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antimicrobial peptides: Role in human disease and potential as immunotherapies
- (2017) César de la Fuente-Núñez et al. PHARMACOLOGY & THERAPEUTICS
- Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-induced Hemorrhagic Cystitis
- (2017) Ethan L. Matz et al. UROLOGY
- Antimicrobial Peptides As Biologic and Immunotherapeutic Agents against Cancer: A Comprehensive Overview
- (2017) Raheleh Roudi et al. Frontiers in Immunology
- Teaching the basics of cancer metabolism: Developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism
- (2017) Balaraman Kalyanaraman Redox Biology
- Peptides with Dual Antimicrobial and Anticancer Activities
- (2017) Mário R. Felício et al. Frontiers in Chemistry
- Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery
- (2017) Michelle C. Salazar et al. JAMA Oncology
- The immune system in cancer metastasis: friend or foe?
- (2017) Louise M.E. Janssen et al. Journal for ImmunoTherapy of Cancer
- Adult T-Cell Leukemia/Lymphoma
- (2017) Neha Mehta-Shah et al. Journal of Oncology Practice
- Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee
- (2016) Jeanne Palmer et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Microtubule destabilising agents: far more than just antimitotic anticancer drugs
- (2016) Darcy Bates et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The challenges of tumor genetic diversity
- (2016) Edmund A. Mroz et al. CANCER
- Stress Chaperone Mortalin Contributes to Epithelial-to-Mesenchymal Transition and Cancer Metastasis
- (2016) Y. Na et al. CANCER RESEARCH
- Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies
- (2016) Gwo Yaw Ho et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Targeted Delivery of Bleomycin: A Comprehensive Anticancer Review
- (2016) Zhiqiang Yu et al. CURRENT CANCER DRUG TARGETS
- The immune system
- (2016) L. B. Nicholson Essays in Biochemistry
- Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences
- (2016) Delisha A. Stewart et al. JOURNAL OF PROTEOME RESEARCH
- LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity
- (2016) Adam Fabisiak et al. Pharmacological Reports
- Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer
- (2016) Paul E. Hughes et al. TRENDS IN IMMUNOLOGY
- Systematic review of ixabepilone for treating metastatic breast cancer
- (2016) Jing Li et al. Breast Cancer
- Epigenetic control of the tumor microenvironment
- (2016) David L Marks et al. Epigenomics
- Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience
- (2016) K Begna et al. Blood Cancer Journal
- Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
- (2016) C. Alix-Panabieres et al. Cancer Discovery
- Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy
- (2016) Ewelina Piktel et al. JOURNAL OF NANOBIOTECHNOLOGY
- Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments
- (2016) Rachel M. McQuade et al. Frontiers in Pharmacology
- Cancer nanomedicine: is targeting our target?
- (2016) Twan Lammers et al. Nature Reviews Materials
- Understanding and Managing Erectile Dysfunction in Patients Treated for Cancer
- (2016) Maria Voznesensky et al. Journal of Oncology Practice
- Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
- (2015) L. Apetoh et al. ANNALS OF ONCOLOGY
- Clinical Next Generation Sequencing for Precision Medicine in Cancer
- (2015) Ling Dong et al. CURRENT GENOMICS
- Drug Delivery Systems and Combination Therapy by Using Vinca Alkaloids
- (2015) Chun-Ting Lee et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cells
- (2015) Katarzyna Niemirowicz et al. International Journal of Nanomedicine
- Novel delivery approaches for cancer therapeutics
- (2015) Ashim K. Mitra et al. JOURNAL OF CONTROLLED RELEASE
- Metabolic reprogramming: the emerging concept and associated therapeutic strategies
- (2015) Go J. Yoshida JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma
- (2015) Doh Yu Hwang et al. LEUKEMIA & LYMPHOMA
- Ibuprofen Induces Mitochondrial-Mediated Apoptosis Through Proteasomal Dysfunction
- (2015) Arun Upadhyay et al. MOLECULAR NEUROBIOLOGY
- CARF (Collaborator of ARF) overexpression in p53-deficient cells promotes carcinogenesis
- (2015) Rajkumar S. Kalra et al. Molecular Oncology
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia
- (2015) Zainul S. Hasanali et al. Science Translational Medicine
- New approaches for cancer immunotherapy
- (2015) Ayfer Karlitepe et al. TUMOR BIOLOGY
- Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?
- (2015) Daniele Fanale et al. Analytical Cellular Pathology
- Human Tumor Antigens and Cancer Immunotherapy
- (2015) Nathalie Vigneron Biomed Research International
- Cancer: We Should Not Forget The Past
- (2015) Anna Di Lonardo et al. Journal of Cancer
- Multifunctional HER2-Antibody Conjugated Polymeric Nanocarrier-Based Drug Delivery System for Multi-Drug-Resistant Breast Cancer Therapy
- (2014) Raju Vivek et al. ACS Applied Materials & Interfaces
- Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
- (2014) M D’Incalci et al. BRITISH JOURNAL OF CANCER
- Beyond BRAF: where next for melanoma therapy?
- (2014) I V Fedorenko et al. BRITISH JOURNAL OF CANCER
- U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
- (2014) H.-Z. Lee et al. CLINICAL CANCER RESEARCH
- Capecitabine Plus Irinotecan Versus 5-FU/Leucovorin Plus Irinotecan in the Treatment of Colorectal Cancer: A Meta-analysis
- (2014) Yuanbiao Guo et al. Clinical Colorectal Cancer
- Sexual dysfunction and infertility as late effects of cancer treatment
- (2014) Leslie R. Schover et al. EJC SUPPLEMENTS
- Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies
- (2014) Rabih Said et al. Expert Opinion on Drug Metabolism & Toxicology
- New advances in the treatment of atrial fibrillation: focus on stroke prevention
- (2014) Yee C Lau et al. EXPERT OPINION ON PHARMACOTHERAPY
- Effectiveness and safety of thiotepa as conditioning treatment prior to stem cell transplant in patients with central nervous system lymphoma
- (2014) Madzouka B. Kokolo et al. LEUKEMIA & LYMPHOMA
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- Cancer-related fatigue—mechanisms, risk factors and treatments
- (2014) Julienne E. Bower Nature Reviews Clinical Oncology
- 6-Thioguanine: A Drug With Unrealized Potential for Cancer Therapy
- (2014) Pashna N. Munshi et al. ONCOLOGIST
- Chemotherapy Enhances Cross-Presentation of Nuclear Tumor Antigens
- (2014) Chidozie C. Anyaegbu et al. PLoS One
- Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis
- (2014) Guan Jiang et al. PLoS One
- The role of reactive oxygen species and metabolism on cancer cells and their microenvironment
- (2014) Ana Costa et al. SEMINARS IN CANCER BIOLOGY
- Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer
- (2014) N Hasima et al. Cell Death & Disease
- Raltitrexed-based chemotherapy for advanced colorectal cancer
- (2014) Y. Liu et al. Clinics and Research in Hepatology and Gastroenterology
- Vaccines for Cancer Prevention: A Practical and Feasible Approach to the Cancer Epidemic
- (2014) O. J. Finn Cancer Immunology Research
- Taxanes
- (2013) Carlton L. Schwab et al. ANTI-CANCER DRUGS
- Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series
- (2013) J. D. Rosenberg et al. BLOOD
- A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis
- (2013) Samira Sadat Abolmaali et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2)
- (2013) Meng-Tao Ma et al. CANCER LETTERS
- Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial
- (2013) Aman U Buzdar et al. LANCET ONCOLOGY
- Chemotherapy-induced mucositis: The role of mucin secretion and regulation, and the enteric nervous system
- (2013) Daniel Thorpe et al. NEUROTOXICOLOGY
- Expression Proteomics Predicts Loss of RXR-γ during Progression of Epithelial Ovarian Cancer
- (2013) Rajkumar S. Kalra et al. PLoS One
- Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs
- (2013) Francesco Torino et al. THYROID
- The war on cancer: are we winning?
- (2013) M. J. Duffy TUMOR BIOLOGY
- Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives
- (2013) Maria Vittoria Dieci et al. Cancer Discovery
- Enhanced levels of double-strand DNA break repair proteins protect ovarian cancer cells against genotoxic stress-induced apoptosis
- (2013) Rajkumar Kalra et al. Journal of Ovarian Research
- Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
- (2013) Metin Karahoca et al. Clinical Epigenetics
- Immune Responses to Cancer: Are They Potential Biomarkers of Prognosis?
- (2013) Theresa L. Whiteside Frontiers in Oncology
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
- (2012) G. Curigliano et al. ANNALS OF ONCOLOGY
- Antibody-Based Immunotherapy of Cancer
- (2012) Louis M. Weiner et al. CELL
- Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells
- (2012) Denis Selimovic et al. CELLULAR SIGNALLING
- Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: Analysis of prospective randomised phase III trials
- (2012) S. Mahner et al. EUROPEAN JOURNAL OF CANCER
- Targeted drug delivery for cancer therapy: the other side of antibodies
- (2012) Michael A Firer et al. Journal of Hematology & Oncology
- Gemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical Modifications
- (2012) Elodie Moysan et al. MOLECULAR PHARMACEUTICS
- Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives
- (2012) George Mattheolabakis et al. Nanomedicine
- Factors Determining Sensitivity and Resistance of Tumor Cells to Arsenic Trioxide
- (2012) Serkan Sertel et al. PLoS One
- Streptozocin-based chemotherapy is not history in neuroendocrine tumours
- (2012) Katie Weatherstone et al. Targeted Oncology
- Using antimicrobial adjuvant therapy in cancer treatment: a review
- (2012) Kenneth Alibek et al. Infectious Agents and Cancer
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- ‘Chemobrain’: concentration and memory effects in people receiving chemotherapy - a descriptive phenomenological study
- (2011) T. MITCHELL et al. EUROPEAN JOURNAL OF CANCER CARE
- Oxaliplatin: a review of approved uses
- (2011) Alexander Stein et al. EXPERT OPINION ON PHARMACOTHERAPY
- Hydroxyurea: a key player in cancer chemotherapy
- (2011) Kapish Madaan et al. Expert Review of Anticancer Therapy
- Chemotherapy, neurotoxicity, and cognitive changes in breast cancer
- (2011) Varsha Dutta Journal of Cancer Research and Therapeutics
- Total Synthesis of Camptothecin and SN-38
- (2011) Shanbao Yu et al. JOURNAL OF ORGANIC CHEMISTRY
- The proliferation rate paradox in antimitotic chemotherapy
- (2011) Timothy J. Mitchison MOLECULAR BIOLOGY OF THE CELL
- HSP70 Inhibition by the Small-Molecule 2-Phenylethynesulfonamide Impairs Protein Clearance Pathways in Tumor Cells
- (2011) J. I.-J. Leu et al. MOLECULAR CANCER RESEARCH
- Cytarabine Dose for Acute Myeloid Leukemia
- (2011) Bob Löwenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- U.S. Food and Drug Administration Approval: Rituximab in Combination with Fludarabine and Cyclophosphamide for the Treatment of Patients with Chronic Lymphocytic Leukemia
- (2011) S. J. Casak et al. ONCOLOGIST
- The European Medicines Agency Review of Tegafur/Gimeracil/Oteracil (Teysuno ) for the Treatment of Advanced Gastric Cancer When Given in Combination with Cisplatin: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use (CHMP)
- (2011) P. Matt et al. ONCOLOGIST
- LC-MS/MS Coupled with Stable Isotope Dilution Method for the Quantification of 6-Thioguanine andS6-Methylthioguanine in Genomic DNA of Human Cancer Cells Treated with 6-Thioguanine
- (2010) Hongxia Wang et al. ANALYTICAL CHEMISTRY
- Arsenic trioxide — An old drug rediscovered
- (2010) Ashkan Emadi et al. BLOOD REVIEWS
- Gene Expression: Protein Interaction Systems Network Modeling Identifies Transformation-Associated Molecules and Pathways in Ovarian Cancer
- (2010) Sharmila A. Bapat et al. CANCER RESEARCH
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- Antibody–drug conjugates: targeted drug delivery for cancer
- (2010) Stephen C Alley et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
- (2010) Dora Dias-Santagata et al. EMBO Molecular Medicine
- Cancer Chemotherapy: An Annotated History
- (2010) W.B. Morrison JOURNAL OF VETERINARY INTERNAL MEDICINE
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?
- (2009) Terence C. Chua et al. ANNALS OF SURGERY
- Mechanisms of anti-cancer action and pharmacology of clofarabine
- (2009) Anna Zhenchuk et al. BIOCHEMICAL PHARMACOLOGY
- Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study
- (2009) K. Schmiegelow et al. BLOOD
- Exploring DNA-Binding Proteins with In Vivo Chemical Cross-Linking and Mass Spectrometry
- (2009) Haibo Qiu et al. JOURNAL OF PROTEOME RESEARCH
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells
- (2009) K Zhu et al. ONCOGENE
- Natural compounds for cancer treatment and prevention
- (2009) Stefania Nobili et al. PHARMACOLOGICAL RESEARCH
- Advances of Cancer Therapy by Nanotechnology
- (2009) Xu Wang et al. Cancer Research and Treatment
- Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells
- (2008) William Ka Kei Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Irinotecan-induced mucositis is associated with changes in intestinal mucins
- (2008) Andrea M. Stringer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Hairy Cell Leukemia: Current Concepts
- (2008) Timothy Cannon et al. CANCER INVESTIGATION
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More